Categories: aggregated

Buy! Sell! Puff, Puff, Pass! – Wall Street Drops Drug Testing for Cannabis, What It Could Mean for Your 401k

This trend among Wall Street institutions reflects a broader reevaluation of cannabis nationwide, influenced by its legal status in multiple U.S. states and evolving public sentiment. The shift is driven in part by practical considerations, such as the difficulty of enforcing stringent drug-free policies in areas where cannabis is legal and the necessity of attracting top talent in a competitive job market.

Jason

Share
Published by
Jason

Recent Posts

Alcohol Is Fun. Hangovers Suck. Here’s What I Drink Instead.

A first-person review of the hemp-derived THC cocktail base I poured at our Cannabis Cup…

19 hours ago

Every Roll of Paper You’ve Touched Comes From a French Invention. The English Took the Credit.

Every paper mill in the world still runs on the continuous-web design a Frenchman patented…

19 hours ago

[Movie Trailer] ‘Cannesabis: Disclosure Night’: The Martians Came to Cannes for the Movies. They Brought Weed.

A new AI-assisted sci-fi satire from filmmaker Dan Levy Dagerman and the Space Weed Universe…

19 hours ago

The Telltale Spark: Spain Dismantled 1,850 Indoor Cannabis Grows by Tracking Illegal Power Hookups in 2025

Spain has increased penalties for electricity theft linked to indoor cannabis cultivation after Endesa reported…

19 hours ago

It’s Never Too Late to Grow Fire

How a 52-year-old first-time grower turned trial and error into a show-stopping harvest The first…

19 hours ago

The Legacy Knowledge Drain: Why Corporate Cannabis is a Dying System

This is the legacy knowledge drain, and it is the quiet catastrophe nobody in the…

19 hours ago